News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Alterity Therapeutics.
RELATED STOCKHEAD STORIES
Investor Guides
Investor Guide: Health & Biotech FY2023
Health & Biotech
ASX Health Stocks: Alterity jumps 20pc after FDA approves its clinical trial in the US
Health & Biotech
This ASX stock is watching you while you sleep… because it could point to Parkinson’s disease
Health & Biotech
ASX Health Stocks: ResApp gets FDA nod, while Japan grants Immutep a patent
Health & Biotech
ASX Health Stocks: Trajan rattles the tin in further $5 million cap raise
Health & Biotech
Check Up: Biotechs are getting crushed, but expert says we shouldn’t dismiss them
Health & Biotech
ASX Health Stocks: Alterity is set to launch Phase 2 clinical trial on Multiple System Atrophy
Health & Biotech
ASX Health Stocks: Crucial new patents have Alterity, Rhythm Biosciences firing in early trade
Health & Biotech
ASX Health Stocks: Opthea and Alterity to present at world renowned biotech conference
Health & Biotech
ASX Health Stocks: Virtus is being pursued as Bionomics prepares for dual Nasdaq listing
Health & Biotech
ASX Health Stocks: Alterity moves to Phase 2 on cancer drug, Race Oncology secures 6th US patent
News
Closing Bell: ASX closes Wednesday 0.38% higher but short of all time high
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Small caps drop, but Afterpay breaks ATH at $159
News
10 at 10: These ASX stocks have put on the best show this morning
News
Last Orders: What you may have missed on the ASX today
News